USRM Chief Science Officer Featured in Powerful Stem Cell Docuseries

SUNRISE, Fla., Jan. 24, 2018 /PRNewswire/ -- U.S. Stem Cell, Inc. (OTC: USRM), a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions, today announced its Chief Science Officer, Dr. Kristin Comella, has been featured in the docuseries, "The Healing Miracle: The Truth About Stem Cells" -- a film that interviews renowned experts in the field of stem cell medicine and explores in-depth the benefits and application of regenerative stem cell therapy.

Dr. Comella, who has more than 20+ years' experience and is one of the world's leading stem cell scientists, has been involved in more than 10,000 stem cell procedures at USRM since 2001.  USRM has pioneered stem cell therapy for damaged tissue from a variety of indications including orthopedic, autoimmune, degenerative and neurological diseases.  USRM also trains and certifies physicians in stem cell therapy -- to date, more than 700+ physicians worldwide --  and has engaged with more than 287 clinics.  Dr. Comella is well published in the scientific literature and has been recognized by her peers as an innovator and world leader in the development and clinical practice of stem cell products and therapies.  She has also been instrumental in developing and bringing to market USRM's Adipocell™ , a stem cell kit which enables physicians to separate stem cells from a patient's own fat cells, which are harvested and reinserted in a minimally invasive, two-hour procedure without general anesthesia.

In the documentary, Dr. Comella (who has worked with all kinds of stem cells including, bone, muscle and fat), recounts an emotional experience with a patient who presented with a two-year-old head trauma and was wheelchair bound.   Following her stem cell protocol with Dr. Comella and USRM, she had a life-changing experience.

Americans in general have been relatively uninformed about the availability of the field of stem cell therapy and regenerative medicine as an option for treating chronic pain conditions, damaged tissue and life-threatening illness. 'The Healing Miracle,' which is produced by Jeff Hays Films, is on a mission to change that trend by shining a light on a field of medicine that has been somewhat sidelined by U.S. regulatory agencies.  Last November, the FDA issued a long-awaited statement indicating it is moving toward integrating stem cell therapy into its code of practice, but concluded by giving itself three years to determine whether it will heavily regulate stem cells in humans as drugs, or continue to allow individuals to have free access to their own healing reserves of stem cells.

"The purpose of this interview is to educate people about cellular medicine -- a concept that has been overshadowed by a pharmaceutical industry that has used disassociation and fear to distract patients from their own healing capabilities," said Dr. Comella.  "This documentary is a great way for the public to learn more about regenerative options available to them --  an alternative to chronic, long-term drug use to managing symptoms, which we all know is often accompanied by debilitating side effects.  There has never been a better time to bring this forward than now, to explore healing regenerative therapies... facing a national emergency around pain management and opioid misuse is a clear wake up call that it's time for better methods."

Dr. Comella is featured in episode 5 of the docuseries, which is available in its entirety online.  To watch just Dr. Comella's interview, click the Brainshark link here and fill out the information which will provide complimentary access.

"We are so proud of Dr. Comella. The world's growing interest in her work and about stem cell therapy and regenerative medicine is an indication our time has come," said Mike Tomas, President and CEO of U.S. Stem Cell, Inc. "Stem cell therapy is rapidly becoming a part of mainstream medicine, and USRM is poised to take the lead in offering this treatment worldwide."

U.S. Stem Cell, Inc. is an emerging leader in the regenerative medicine / cellular therapy industry specializing in physician training and certification and stem cell products including its lead product Adipocell™ , as well as veterinary stem cell training and stem cell banking and creation and management of stem cell clinics.  To management's knowledge, USRM has completed more clinical treatments than any other stem cell company in the world in the past 20 years, and has certified more than 700 physicians and veterinarians in autologous stem cell therapy worldwide. 

Forward-Looking Statements: Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "plan", "expect", "believe", "anticipate", "intend", "could", "would", "estimate", or "continue", or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements and represent our management's beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future. The Company's business and the risks and uncertainties of the business are described in its filings with the Securities and Exchange Commission which can be found at sec.gov.

Media Contact: U.S. Stem Cell, Inc.
13794 NW 4th Street, Suite 212
Sunrise, Fl 33325
Phone: 954.835.1500
Email: [email protected]

SOURCE U.S. Stem Cell, Inc.